Folic acid rescue of ATRA-induced cleft palate by restoring the TGF-β signal and inhibiting apoptosis

Journal of Oral Pathology and Medicine

Volumn 40, Issue 5, 2011, Pages 433-439

  Yao, Zhaoyou ^a   Chen, Dan ^a   Wang, Anxun ^a   Ding, Xueqiang ^a   Liu, Zhonghua ^a   Ling, Li ^a   He, Qianting ^a   Zhao, Tingting ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Cleft palate; Embryonic palatal mesenchyme; Folic acid; Retinoic acid; TGF signaling

Indexed keywords

CASPASE 9; FOLIC ACID; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CLEFT PALATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MESENCHYME; MICROSCOPY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPPLEMENTATION; TISSUE CULTURE;

ANIMALS; APOPTOSIS; CASPASE 9; CELLS, CULTURED; CLEFT PALATE; FOLIC ACID; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TERATOGENS; TRANSFORMING GROWTH FACTOR BETA3; TRETINOIN; VITAMIN B COMPLEX;

EID: 79954559641     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00994.x     Document Type: Article

References (37)

1. Gritli-Linde A. Molecular control of secondary palate development. Dev Biol 2007; 301: 309-26.
2. Rice DP. Craniofacial anomalies: from development to molecular pathogenesis. Curr Mol Med 2005; 5: 699-722.
3. Bianchi F, Calzolari E, Ciulli L, et al. Environment and genetics in the etiology of cleft lip and cleft palate with reference to the role of folic acid. Epidemiol Prev 2000; 24: 21-7.
4. Wang M, Huang H, Chen Y. Smad2/3 is involved in growth inhibition of mouse embryonic palate mesenchymal cells induced by all-trans retinoic acid. Birth Defects Res A Clin Mol Teratol 2009; 85: 780-90.
5. He W, Meng T, Lu SJ, et al. Vitamin B12 counteracts dexamethasone-induced proliferation and apoptosis during key periods of palatogenesis in mice. Ann Plast Surg, 2010; 64: 466-70.
6. Wang A, Ding X, Sheng S, Yao Z. Retinoic acid inhibits osteogenic differentiation of rat bone marrow stromal cells. Biochem Biophys Res Commun 2008; 375: 435-9.
7. Yu Z, Lin J, Xiao Y, et al. Induction of cell-cycle arrest by all-trans retinoic acid in mouse embryonic palatal mesenchymal (MEPM) cells. Toxicol Sci 2005; 83: 349-54.
8. Lu SJ, He W, Shi B, Meng T, Li XY, Liu YR. A preliminary study on the teratogenesis of dexamethasone and the preventive effect of vitamin B12 on murine embryonic palatal shelf fusion in vitro. J Zhejiang Univ Sci B 2008; 9: 306-12.
9. Weingartner J, Lotz K, Fanghanel J, Gedrange T, Bienengraber V, Proff P. Induction and prevention of cleft lip, alveolus and palate and neural tube defects with special consideration of B vitamins and the methylation cycle. J Orofac Orthop 2007; 68: 266-77.
10. Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005; 81: 1213S-7S.
11. Antony AC. In utero physiology: role of folic acid in nutrient delivery and fetal development. Am J Clin Nutr 2007; 85: 598S-603S.
12. Ray JG, Meier C, Vermeulen MJ, Wyatt PR, Cole DE. Association between folic acid food fortification and congenital orofacial clefts. J Pediatr 2003; 143: 805-7.
13. Badovinac RL, Werler MM, Williams PL, Kelsey KT, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 2007; 79: 8-15.
14. Xiao WL, Wu M, Shi B. Folic acid rivals methylenetetrahydrofolate reductase (MTHFR) gene-silencing effect on MEPM cell proliferation and apoptosis. Mol Cell Biochem 2006; 292: 145-54.
15. Bliek BJ, Steegers-Theunissen RP, Blok LJ, et al. Genome-wide pathway analysis of folate-responsive genes to unravel the pathogenesis of orofacial clefting in man. Birth Defects Res A Clin Mol Teratol 2008; 82: 627-35.
16. Cuervo R, Valencia C, Chandraratna RA, Covarrubias L. Programmed cell death is required for palate shelf fusion and is regulated by retinoic acid. Dev Biol 2002; 245: 145-56.
17. Xu Y, Li L, Zhang Z, Li Y. Effects of folinic acid and Vitamin B12 on ethanol-induced developmental toxicity in mouse. Toxicol Lett 2006; 167: 167-72.
18. Pungchanchaikul P, Gelbier M, Ferretti P, Bloch-Zupan A. Gene expression during palate fusion in vivo and in vitro. J Dent Res 2005; 84: 526-31.
19. Johansen AM, Lie RT, Wilcox AJ, Andersen LF, Drevon CA. Maternal dietary intake of vitamin A and risk of orofacial clefts: a population-based case-control study in Norway. Am J Epidemiol 2008; 167: 1164-70.
20. Yu Z, Xing Y. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. Biochem Biophys Res Commun 2006; 340: 929-34.
21. Wilcox AJ, Lie RT, Solvoll K, et al. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 2007; 334: 464.
22. Jin JZ, Ding J. Analysis of cell migration, transdifferentiation and apoptosis during mouse secondary palate fusion. Development 2006; 133: 3341-7.
23. Okano J, Suzuki S, Shiota K. Involvement of apoptotic cell death and cell cycle perturbation in retinoic acid-induced cleft palate in mice. Toxicol Appl Pharmacol 2007; 221: 42-56.
24. Wang R, Liu B, Wang B, Cong W, Xiao J. Spatial and temporal changes of palatal cell proliferation and cell apoptosis of retinoic acid induced mouse cleft palate in different embryonic stages. Hua Xi Kou Qiang Yi Xue Za Zhi 2008; 26: 546-9.
25. Suwa F, Jin Y, Lu H, et al. Alteration of apoptosis in cleft palate formation and ectomesenchymal stem cells influenced by retinoic acid. Okajimas Folia Anat Jpn 2001; 78: 179-86.
26. Denault JB, Salvesen GS. Apoptotic caspase activation and activity. Methods Mol Biol 2008; 414: 191-220.
27. Oudejans JJ, Muris JJ, Meijer CJ. Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Cell Cycle 2005; 4: 526-8.
28. Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn 1997; 209: 255-60.
29. Nakajima A, Ito Y, Asano M, et al. Functional role of transforming growth factor-beta type III receptor during palatal fusion. Dev Dyn 2007; 236: 791-801.
30. Wang W, Huang XR, Li AG, et al. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005; 16: 1371-83.
31. Nawshad A, LaGamba D, Hay ED. Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 2004; 49: 675-89.
32. Dudas M, Nagy A, Laping NJ, Moustakas A, Kaartinen V. Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. Dev Biol 2004; 266: 96-108.
33. Taya Y, O'Kane S, Ferguson MW. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 1999; 126: 3869-79.
34. Nugent P, Pisano MM, Weinrich MC, Greene RM. Increased susceptibility to retinoid-induced teratogenesis in TGF-beta2 knockout mice. Reprod Toxicol 2002; 16: 741-7.
35. Huang HZ, Lu BH, Chen YY, Liao GQ. Study on etiology of retinoic acid-induced cleft palate in mouse. Zhonghua Kou Qiang Yi Xue Za Zhi 2003; 38: 185-7.
36. Nugent P, Ma L, Greene RM. Differential expression and biological activity of retinoic acid-induced TGFbeta isoforms in embryonic palate mesenchymal cells. J Cell Physiol 1998; 177: 36-46.
37. Baroni T, Bellucci C, Lilli C, et al. Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype. Mol Med 2006; 12: 237-45.